The payroll tax cut has been a constant Trump administration priority during the coronavirus crisis. Another constant has been a lack of enthusiasm for the idea elsewhere in Washington. ...
Many small biotech players have put the foot on the gas in 2020. With the urgent need for a COVID-19 vaccine and treatment still the number one global priority, this comes as no surprise.Athersys (ATHX) is among those to rise to the challenge and the market has rewarded the micro-cap accordingly. Shares have appreciated by 114% since the turn of the year.Yet, Dawson James analyst Jason Kolbert believes the upward movement has a long way to go.Kolbert reiterated a Buy rating on ATHX shares along with a $12 price target. Investors can expect returns of a whopping 360%, should the target be met over the coming year. (To watch Kolbert’s track record, click here)Following the recent clearance from the FDA, a Phase 2/3 ARDS (acute respiratory distress syndrome) trial has kicked into gear at the University of Cleveland Medical Center (UHC), with the first patient enrolled. The study will evaluate Athersys’...
Neste, one of the world’s leading producers of renewable fuels, has announced the closing of its acquisition of its largest single investment in the U.S. to date. ...
FLINS-SUR-SEINE, France (Reuters) - With temperature scanners on the door and tables partitioned by plexiglass shields in the breakout area, workers at one of Renault's French plants are adjusting to new routines as carmakers try to cope with the coronavirus crisis. Like peers across Europe, Renault is gradually ramping up production after stoppages linked to the outbreak, as governments begin to ease some lockdown rules. Inside the Flins factory northwest of Paris, where Renault makes its electric Zoe models and the Micra car for its partner Nissan, sanitary protocols now restrict even the way coffee breaks are held - in a glimpse of measures to expect in other industries as shutdowns are further lifted....
